Community Research and Development Information Service - CORDIS

Horizon 2020 project information and now also report summaries are available on CORDIS. All H2020 projects can be downloaded from the EU Open Data Portal .

My refinements


Download results of this page


Refine by:

Advanced search

Search projects and results

Results 1 - 10 of 16
Results/page:
12 > 
Placental Growth Factor (PlGF): new diagnostic and therapeutic applications in cardiovascular disease
ID: 37254
Start date: 2007-01-01, End date: 2009-03-31
The proposed Strep evaluates the potential of PlGF as a pharmaceutical for major chronic progressive cardiac disorders (ischemic heart disease, heart failure and arterial insufficiency (intermittent claudication and critical limb ischemia)) and as a biomarker for cardiovascula...
Programme: FP6-LIFESCIHEALTH
Record Number: 84951
Last updated on: 2013-03-26
Development of New Drugs for the Treatment of Malaria
ID: 18834
Start date: 2005-12-01, End date: 2011-05-31
Leading groups of malaria researchers will integrate their expertise in malaria biology and drug development to exploit new scientific and political opportunities to secure the development of a portfolio of viable novel AntiMalarial drugs. New chemical entities will be commerc...
Programme: FP6-LIFESCIHEALTH
Record Number: 78405
Last updated on: 2011-12-20
RNA Interference Technology as Human Therapeutic Tool
ID: 5276
Start date: 2005-01-01, End date: 2009-06-30
The RIGHT project aims at exploiting the vast potential of RNA interference (RNAi) for human therapy, based on an advanced understanding of the underlying mechanisms. Rational and selective approaches will be taken to generate efficient RNAi reagents, and strategies will be de...
Programme: FP6-LIFESCIHEALTH
Record Number: 74045
Last updated on: 2013-03-26
Ration design and standardized evaluation of novel genetic vaccines.
ID: 5246
Start date: 2005-01-01, End date: 2009-06-30
Recombinant viral vectors and virus-like particles are considered the most promising vehicles to deliver antigens in prophylactic and therapeutic vaccines against infectious diseases and cancer. Several potential vaccine designs exist but their cost-effective development cruel...
Programme: FP6-LIFESCIHEALTH
Record Number: 74040
Last updated on: 2013-03-26
Improving project & research management skills in third countries to stumulate their cooperatin with Europe for life- sciences
ID: 512108
Start date: 2004-10-01, End date: 2006-09-30
Life science research is increasingly global. Much research potential outside Europe in this field remains untapped: many excellent research teams in various third countries around the globe would like to co-operate with Europe at the level they do with US organizations, but a...
Programme: FP6-LIFESCIHEALTH
Record Number: 74097
Last updated on: 2010-01-04
The Alternate Transcript Diversity Project
ID: 503329
Start date: 2004-03-01, End date: 2007-02-28
Production of mature mRNA transcripts in vertebrates is regulated at three stages: transcription initiation, splicing and polyadenylation. The combinatorial arrangement of variations at each stage generates, from a single gene, a variety of mRNA isoforms with different start s...
Programme: FP6-LIFESCIHEALTH
Record Number: 75299
Last updated on: 2013-03-26
STANDARDISATION OF HIV NEUTRALISATION ASSAYS TO BE USED IN VACCINE RESEARCH AND CLINICAL TRIALS
ID: 12190
Start date: 2005-01-01, End date: 2007-03-31
The efficacy of viral vaccines can be confirmed by large sero-epidemiological studies where occurrence of a certain type(s) of functional antibody correlates with protection. In general, antibodies with virus neutralising function are the best correlates o f protection. Follow...
Programme: FP6-LIFESCIHEALTH
Record Number: 74056
Last updated on: 2008-07-21
New medicines for tuberculosis
[PROJECT] NM4TB - New medicines for tuberculosis
ID: 18923
Start date: 2006-01-01, End date: 2011-06-30
The explicit aim of the NM4TB project is to successfully develop new drugs for the treatment of tuberculosis (TB) with the following desired properties: * High potency to reduce treatment duration, * Activity against persistent bacilli, * Inhibition of ne w target classes, * A...
Programme: FP6-LIFESCIHEALTH
Record Number: 78442
Last updated on: 2012-12-21
European Microbicides Project
[PROJECT] EMPRO - European Microbicides Project
ID: 503558
Start date: 2004-01-01, End date: 2009-12-31
This proposal aims to develop new topical microbicides that block entry of HIV at mucosal sites with the aim of establishing a pipeline of candidate microbicides while taking selected microbicides through Phase I clinical trial. The proposed programme will bring together leadi...
Programme: FP6-LIFESCIHEALTH
Record Number: 78712
Last updated on: 2011-11-30
Effect of genetic variation in Mycobacterium tuberculosis on vaccine escape and the acquisition of drug resistance
ID: 37919
Start date: 2006-12-01, End date: 2010-05-31
Tuberculosis (TB) remains a major public health threat, still emerging in some areas of the world. The major tools to control the TB epidemic are worldwide implementation of the directly observed therapy short course (DOTS) programme and BCG vaccination. However, these methods...
Programme: FP6-LIFESCIHEALTH
Record Number: 85517
Last updated on: 2011-09-02
12 > 
List retrieved on: 2017-05-27
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top